Chadi Nabhan

6PUBLICATIONS
99CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 21, 2025
Inhibition of PIM Kinase in Tumor-Associated Macrophages Suppresses Inflammasome Activation and Sensitizes Prostate Cancer to Immunotherapy.

Amber N Clements, Andrea L Casillas, Caitlyn E Flores

|Jan 02, 2025
Structurally Oriented Classification of FOXA1 Alterations Identifies Prostate Cancers with Opposing Clinical Outcomes and Distinct Molecular and Immunologic Subtypes.

Justin Hwang, Pornlada Likasitwatanakul, Sachin Kumar Deshmukh

|Jun 24, 2024
Characterization of Wnt Signaling Pathway Aberrations in Metastatic Prostate Cancer.

Sharon H Choi, Elizabeth Pan, Andrew Elliott

|May 06, 2024
Pan-Cancer Interrogation of B7-H3 (CD276) as an Actionable Therapeutic Target Across Human Malignancies.

Carly D Miller, John R Lozada, Nicholas A Zorko

|May 01, 2023
Metastatic Prostate Cancers with BRCA2 versus ATM Mutations Exhibit Divergent Molecular Features and Clinical Outcomes.

Justin Hwang, Xiaolei Shi, Andrew Elliott

|Sep 16, 2022
Multi-omic Characterization of Pancreatic Ductal Adenocarcinoma Relates CXCR4 mRNA Expression Levels to Potential Clinical Targets.

Florian Kocher, Alberto Puccini, Gerold Untergasser

Pageof 1